Protein dynamics analysis identifies candidate cancer driver genes and mutations in TCGA data

Jan Fehmi Sayılgan1, Türkan Haliloğlu2,3, Mehmet Gönen4,5

  • 1Graduate School of Sciences and Engineering, Koç University, İstanbul, Turkey.

Proteins
|February 7, 2021
PubMed

Insights

Cancer missense mutations cluster around protein hinge residues, offering a new way to find novel cancer genes and mutations. This computational approach enhances understanding of mutation impact and pathogenicity prediction.

Area of Science:

  • Genomics
  • Computational Biology
  • Cancer Research

Background:

  • Cancer missense mutations often target hinge residues, critical for protein dynamics.
  • Identifying novel cancer-related mutations and genes is crucial for advancing cancer research.

Purpose of the Study:

  • To develop a computational pipeline for detecting 3D clustering of missense mutations around hinge residues.
  • To identify novel candidate cancer genes and mutations using this approach.
  • To improve the prediction of missense mutation pathogenicity.

Main Methods:

  • Applied a Gaussian network model to detect hinge residues.
  • Developed a computational pipeline to analyze 3D mutation clustering.
  • Systematically analyzed the PanCancer compendium of somatic mutations from The Cancer Genome Atlas (TCGA).

Main Results:

  • Identified significantly enriched 3D clustering of missense mutations around hinge residues in known cancer genes (e.g., CDK4, CDKN2A, TCL1A, MAPK1).
  • Discovered significantly enriched clustering in PLA2G4A, potentially linking it to excessive extracellular signal-regulated kinase phosphorylation.
  • Demonstrated that hinge-based features improve missense mutation pathogenicity prediction.

Conclusions:

  • Clustering analysis around hinge residues aids in explaining the functional role of mutations in known cancer genes.
  • This approach successfully identifies novel candidate cancer genes and mutations.
  • The findings provide a new perspective on cancer mutation analysis and discovery.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
52.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K